TOKENPOST
1 min read
Add as a preferred source on Google

HLS Therapeutics Figures Show Revenue of $14.2 Million

GAAP earnings per share is listed as a loss of $0.07.

By John Kim
Published
NO STORY 관련 이미지 / TokenPost.ai
NO STORY 관련 이미지 / TokenPost.ai

The figures listed for HLS Therapeutics include $14.2 million in revenue and a GAAP loss of $0.07 per share. Earnings per share expresses a company's profit or loss on a per-share basis, while GAAP refers to generally accepted accounting principles.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…